COSM (Cosmos Health Inc) מכפיל P/E עתידי

The forward P/E of the business on the GURU.Markets daily chart illustrates the valuation trend, where the 3.80 mark reflects the latest data. Cosmos Health Inc. (COSM) is building a vertically integrated holding company, combining generic drug production and pharmacy retail in Europe. Growth is driven by AI-powered development of new formulas and the expansion of nutraceutical brands. Modernization relies on autonomous warehouse logistics and the robotization of filling lines.

The development of European distribution and the expansion of dietary supplement brands by Cosmos Health Inc. (COSM) are reflected in the company's forward 12-month P/E ratio, which compares current market capitalization with projected net income. This indicator measures the cost of one dollar of future earnings, allowing investors to assess the premium paid for the asset considering the digitalization costs of the pharmacy business already priced in.